Former Cooley Godward Partner’s Public Company and Life Sciences Expertise to Fuel Expansion of West Coast Corporate Practice
SAN DIEGO– LAWFUEL – The Law News Wire – After nearly eight years as Vice President and General Counsel of San Diego-based Hollis-Eden Pharmaceuticals, Eric Loumeau has returned to private practice, joining the San Diego office of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. as a Member in the Corporate group.
Mr. Loumeau is the first of what is expected to be several high-profile additions, as Mintz Levin expands its international life sciences practice to the West Coast. He brings vast experience representing public life science and technology companies in complex transactions, and advising them on securities laws and corporate governance and compliance matters, all of which will be an immediate and significant benefit to Mintz Levin clients throughout California and beyond.
“This is a big day for Mintz Levin,” said Craig Hunsaker, Managing Member of the firm’s San Diego office. “Many of us know Eric well – as a former colleague, client, or from working opposite him on deals. He is an outstanding, focused lawyer and tireless worker; but as important, he is a terrific person. You cannot help but respect and admire him, not only for what he does but for who he is. We know Eric was in high demand, and could not be more pleased that he has chosen to join the Mintz Levin team.”
At Hollis-Eden, in addition to serving as the company’s General Counsel, Mr. Loumeau was Chief Compliance Officer, responsible for ensuring the company’s compliance with Sarbanes Oxley and related SEC and NASDAQ rules and regulations. He oversaw nearly a dozen financings and acquisitions, and negotiated numerous licensing, research and clinical trial agreements, including with the U.S. government.
Prior to joining Hollis-Eden, Mr. Loumeau was a Partner at the San Diego office of Cooley Godward LLP, where his practice encompassed a full range of corporate and securities matters for public and private companies including financings and mergers and acquisitions. In particular, he completed more than 20 public offerings, both equity and debt, for many life science and technology industry leaders, including such local companies as: Amylin Pharmaceuticals, QUALCOMM, Aurora Biosciences, DataWorks Corporation, The Titan Corporation and Hollis-Eden. He has also represented numerous investment banks including Merrill Lynch, UBS Securities, Robertson Stephens, DLJ Securities and Jefferies & Co., in major offerings. Mr. Loumeau began his career at Skadden, Arps, Slate, Meagher & Flom where he gained significant experience representing private and public companies in corporate and securities matters.
“Eric brings with him a unique perspective, having been highly successful in private practice and as General Counsel of a public drug discovery company,” said Steve P. Rosenthal, Co-Managing Member of Mintz Levin. “He has an ‘insider’s’ understanding of the issues facing life science companies whether they are under intense regulatory scrutiny, looking for financing or preparing for a public offering. His combination of experience managing public company legal affairs from the inside, and structuring complex debt and securities transactions as outside counsel, will be of immeasurable benefit to current and future Mintz Levin clients.”
Mr. Loumeau attended Harvard Law School and the University of California, Berkeley, Boalt Hall School of Law, where he earned his law degree. He received his Bachelor’s Degree in Finance from Brigham Young University.
Mintz Levin represents biotechnology, pharmaceutical and medical device companies, as well as research institutes and institutions of higher education, located throughout the United States, Europe and Asia, in a broad range of transactional, regulatory, counseling and intellectual property matters. The firm’s life sciences service teams include more than one hundred attorneys and senior professionals with industry-specific experience and knowledge of finance, management and systems, clinical strategy, regulatory affairs, licensing, patents, corporate transactions, tax, manufacturing, accounting, product economics and real estate.
Mintz Levin is an AmLaw 100 law firm with offices in the US and the UK. The firm has exceptional depth in a broad range of practice areas, but our clients recognize that what sets us apart from other law firms is our industry focus. By truly understanding business drivers and industry trends, we are able to provide our clients with more than just legal advice. We provide legal solutions to our clients’ business issues. Since 1933, our lawyers have represented entrepreneurs, emerging growth companies, government agencies, and leaders in primary industries that include Life Sciences/Biotechnology; Technology & Communications; Energy & Clean Technology; Financial Services & Insurance; Healthcare; Real Estate, Hospitality & Construction; and Retail & Consumer Products. Our practical knowledge combined with our industry expertise enables us to provide our clients with enterprise legal advice that gives their business a competitive advantage in the marketplace. For detailed information on the firm we invite you to visit www.mintz.com.